Guardant Health, Inc.
N/MPrice / tangible book
Market cap
$21.66B
Tangible equity
-$202.49M
Price / tangible book
N/M
Price / book
N/M
Return on equity
419.2%
Return on assets
-20.7%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: GH stock price vs MS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MS's multiple
Needs Book value / share is negative.
Implied fair value · at GH's multiple
Needs GH P/B is negative.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Multiple discount
Multiple discount
Profitability edge
Asset efficiency lag
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: GH FY 2025 (ended Dec 31, 2025) · MS FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / tangible book
Market cap
$21.66B
Tangible equity
-$202.49M
Price / tangible book
N/M
Price / book
N/M
Return on equity
419.2%
Return on assets
-20.7%
Efficiency ratio
—
Price / tangible book
Market cap
$341.94B
Tangible equity
$88.90B
Price / tangible book
3.85x
Price / book
3.06x
Return on equity
15.1%
Return on assets
1.2%
Efficiency ratio
40.4%
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
GUARDANT HEALTH, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
MORGAN STANLEY · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-15.14x
3.06x
Net debt / EBITDA
Leverage against operating earnings
-3.04x
3.32x
Cash and equivalents
Liquid reserves on the balance sheet
$378.20M
$111.70B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
NEOGENOMICS INC
GH vs NEO
Fulgent Genetics, Inc.
GH vs FLGT
EXACT SCIENCES CORP
GH vs EXAS
Natera, Inc.
GH vs NTRA
The Goldman Sachs Group, Inc.
GH vs GS
JPMorgan Chase & Co.
GH vs JPM
Bank of America Corporation
GH vs BAC
Citigroup Inc.
GH vs C
SCHWAB CHARLES CORP
GH vs SCHW
Wells Fargo & Company
GH vs WFC
$1.50B
$341.68B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.